1-(Tributylstannyl)methanol → (1-(4,5-Dihydro-1H-imidazol-2-yl)isochroman-5-yl)methanol
反応式
Br[C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH2:4][CH2:5][O:6][CH:7]2[C:12]1[NH:13][CH2:14][CH2:15][N:16]=1.C([Sn]([CH2:30][OH:31])(CCCC)CCCC)CCC>>[NH:13]1[CH2:14][CH2:15][N:16]=[C:12]1[CH:7]1[C:8]2[C:3](=[C:2]([CH2:30][OH:31])[CH:11]=[CH:10][CH:9]=2)[CH2:4][CH2:5][O:6]1参加物
3
実験手順
The title compound was prepared from 2-(5-bromoisochroman-1-yl)-4,5-dihydro-1H-imidazole (50 mg) and (tributylstannyl)methanol (86 mg) by using tetrakis(triphenyl-phosphine)palladium (10.28 mg) as catalyst, and the procedure of synthesis method C and separation methods F and G. (Yield 6.2 mg).
後処理
- customthe procedure of synthesis method C and separation methods F and G
出典と根拠
- ORDレコード
- ord-ceaa6c2a00dd4123ab46110c52170bf6
- 出典データセット
- uspto-grants-2016_02
- 特許番号
- US09249127B2
反応ノート
読み込み中…